• PRALATREXATE chembl:CHEMBL1201746 ApprovedAntineoplasticImmunotherapy

    Alternate Names:

    PDX
    PRALATREXATE
    FOLOTYN
    N-(4-(1-((2,4-DIAMINO-6-PTERIDINYL)METHYL)-3-BUTYNYL)BENZOYL)-L-GLUTAMIC ACID
    HSDB 7786
    (2S)-2-((4-((1RS)-1-((2,4-DIAMINOPTERIDIN-6-YL)METHYL)BUT-3-YNYL)BENZOYL)AMINO)PENTANEDIOIC ACID
    PRALATREXATUM
    FOLOTYN®
    PRALATREXATO
    (2S)-2-({4-[1-(2,4-DIAMINOPTERIDIN-6-YL)PENT-4-YN-2-YL]BENZOYL}AMINO)PENTANEDIOIC ACID
    10-PROPARGYL-10-DEAZAAMINOPTERIN
    pubchem.compound:148121
    rxcui:662019
    chembl:CHEMBL1201746
    drugbank:06813
    chemidplus:146464-95-1

    Drug Info:

    Year of Approval 2009
    Drug Class antineoplastic agents
    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    FDA Approval 2009
    Drug Indications Antineoplastic Agents
    (4 More Sources)